Fig. 5From: In silico trial to test COVID-19 candidate vaccines: a case study with UISS platformAntibody-mediated neutralization of SARS-CoV-2 infection on simulated lung epithelial cells. 10Â ng/ml revealed the best concentration to obtain maximum clearance of the virusBack to article page